Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

Draw of bank line of credit - - 655,000

Repayment of bank line of

credit - - (655,000)

Bridge loan - - 300,000

Repayment of bridge loan - - (300,000)

Repayment of capital lease

and equipment financing

obligations (6,370) (5,941) (303,061)

-----------------------------------------------------------------------

417,941 (5,941) 39,931,880

Investing activities:

Purchase of short-term

investments - (2,577,726) (44,450,921)

Maturity of short-term

investments 1,299,844 7,662,879 44,450,921

Leasehold inducements - - 243,780

Long-term investment - - (20,000)

Acquisition of facilities

and equipment (51,129) (295,296) (3,030,639)

Disposal of equipment - - 8,986

-----------------------------------------------------------------------

-----------------------------------------------------------------------

1,248,715 4,789,857 (2,797,873)

Increase in cash & cash

equivalents (1,217,149) 2,596,213 8,543,124

Cash & cash equivalents,

beginning of period 9,760,273 4,824,896 -

-------------------------------------------------------------------------

Cash & cash equivalents,

end of period 8,543,124 7,421,109 8,543,124

-------------------------------------------------------------------------

----------
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 On June 11, 2013 ... released a final decision memorandum concluding that FDG Position ... management of anti-tumor strategy, and the agency ended ... Oncological PET Registry (NOPR) was developed jointly by the ... under the Coverage with Evidence Development (CED) program to ...
(Date:6/18/2013)... 2013 Kitware , a leading ... new Fast-Track award from the U.S. Department of Energy ... for the nuclear power industry. , Construction of nuclear ... 30 years, but the United States’ nuclear power industry ... power plant utilization through improved refueling, maintenance, and safety ...
(Date:6/17/2013)... , June 17, 2013  KaloBios Pharmaceuticals, Inc. ... of Donald R. Joseph as Chief Legal ... of biopharmaceutical industry experience and has worked in both ... health non-profit organizations. (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ... track record as a general counsel and senior executive ...
(Date:6/17/2013)... June 17, 2013 The Defense Threat ... Technical Review at the Waterford in Springfield, Virginia on ... grant awardees will present technical details on their counter ... cover a broad range of counter WMD areas including: ... and Network Science; (3) Science for Protection; (4) Science ...
Breaking Biology Technology:WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2
... "BioMS/Eli Lilly - Dissecting a Billion Dollar Collaboration" ... - BioMS Medical Corp (TSX: MS), a leading ... today announced that Mr. Richard Brown, Vice President, ... Senior Director, Corporate Business Development, Eli Lilly and ...
... May 14 - Bioniche Pharma, a leading ... launch of Enlon (R) (edrophonium chloride injection, ... sulfate, USP) Injection. (Logo: http://www.newscom.com/cgi-bin/prnh/20080702/AQW070LOGO )"The ... Bioniche,s continued growth and a commitment to bringing ...
... 14 Nucletron, a,knowledge-based leader in radiation ... Brachy, a comprehensive film- and volume-based treatment,planning ... brachytherapy.,Oncentra Brachy, the world,s first fully DICOM-compatible ... system that features,state-of-the-art optimization algorithms to ensure ...
Cached Biology Technology:BioMS Medical to participate in panel session at Bio International Convention 2009 2Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions 2
(Date:6/18/2013)... 2013). A team of internationally recognized feline experts including ... from the University of Lincoln, U.K. and Dr Ilona ... invited by the International Society of Feline Medicine (ISFM) ... compile guidelines for veterinarians, owners and those working with ... the domestic cat. The new guidelines appear in the ...
(Date:6/17/2013)... with central nervous system infections may well be suffering ... to a study to be published in mBio ... for Microbiology. Researchers have detected the virus in spinal ... nervous system infections of unknown cause, and in an ... and poultry, suggesting animals may serve as reservoirs for ...
(Date:6/17/2013)... 17, 2013How kids eat their food may turn out to ... a new study out of St. Michael,s Hospital. , ... found a significant association between poor eating habits in ... or "bad" cholesterol, putting them at risk for ... in the Canadian Medical Association Journal today. ...
Breaking Biology News(10 mins):Feline behavior experts release guidelines to improve the welfare of cats 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3Poor eating behaviors may put preschoolers at risk for later health problems 2
... University of Florida researchers have identified a gene variation ... physical effects of mental stress to the point where ... for the presence of this gene may be one way ... for the phenomenon, said David S. Sheps, M.D., a professor ...
... have an increased risk of wheezing in the chest if they ... This is shown in a new study using data from the ... Public Health (NIPH). The results come from a ... of these children took part in baby swimming from 0-6 months ...
... investigation of the genes that govern spore formation in the ... in determining which of the microbes sacrifice themselves for the ... subtilis, a common soil bacteria, is a well-known survivor. When ... colonies or encase itself in a tough, protective spore to ...
Cached Biology News:Mental stress reduces blood flow to the heart in patients with gene variation 2Mental stress reduces blood flow to the heart in patients with gene variation 3Possible link between baby swimming and breathing problems in children 2Are sacrificial bacteria altruistic or just unlucky? 2
... Provides a fast and easy method ... mitochondrial fraction from mammalian tissues. Most ... inner and outer membranes. The kit ... studies and proteome profiling. Also included ...
... and other fluid sources for 4 vessels ... of each individual pump is controlled electronically. ... exactly maintained. ,High-precision controlled peristaltic pumps ... which allows flow rates between 0.01 to ...
... The SearchLight® IR Mouse Cytokine Array ... assay) for the quantitative measurement of 12 ... plasma and culture supernatants. Each well of ... that capture specific cytokines in standards and ...
... cassette is designed to allow ampicillin selection ... gb2 driving the gene for ampicillin resistance ... Em7 promoter. It mediates higher transcription efficiency ... synthetic polyadenylation signal terminates the ampicillin expression. ...
Biology Products: